SYNAPSE®: INTERIM UPDATE ON BHR-100-301, A GLOBAL PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PROGESTERONE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY (TBI)

被引：0
作者：
Nelson, Neta R.
van der Hoop, Roland Gerritsen
机构：
来源：
JOURNAL OF NEUROTRAUMA | 2013年 / 30卷 / 15期
关键词：
clinical trial; TBI;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A168 / A168
页数：1
相关论文
共 50 条
  • [21] Early Survival of Comatose Patients after Severe Traumatic Brain Injury with the Dual Cannabinoid CB1/CB2 Receptor Agonist KN38-7271: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial
    Firsching, Raimund
    Piek, Juergen
    Skalej, Martin
    Rohde, Veit
    Schmidt, Uwe
    Striggow, Frank
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2012, 73 (04) : 204 - 216
  • [22] RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial
    Holubovska, Olga
    Babich, Pavlo
    Mironenko, Alla
    Milde, Jens
    Lebed, Yuriy
    Stammer, Holger
    Mueller, Lutz
    te Velthuis, Aartjan J. W.
    Margitich, Victor
    Goy, Andrew
    ADVANCES IN RESPIRATORY MEDICINE, 2024, 92 (03) : 202 - 217
  • [23] Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
    Takahashi, Satoru
    Kato, Kumiko
    Yokoyama, Osamu
    Takei, Mineo
    Gotoh, Momokazu
    JOURNAL OF UROLOGY, 2024, 212 (02) : 267 - 279
  • [24] Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial
    Choi, C. H.
    Kwon, J. G.
    Kim, S. K.
    Myung, S. -J.
    Park, K. S.
    Sohn, C. -I.
    Rhee, P. -L.
    Lee, K. J.
    Lee, O. Y.
    Jung, H. -K.
    Jee, S. R.
    Jeen, Y. T.
    Choi, M. -G.
    Choi, S. C.
    Huh, K. C.
    Park, H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (05) : 705 - 716
  • [25] N-protein vaccine is effective against COVID-19: phase 3, randomized, double-blind, placebo-controlled clinical trial
    Rabdano, Sevastyan O.
    Ruzanova, Ellina A.
    Vertyachikh, Anastasiya E.
    Teplykh, Valeriya A.
    Emelyanova, Alla B.
    Rudakov, German O.
    Arakelov, Sergei A.
    Pletyukhina, Iuliia V.
    Saveliev, Nikita S.
    Lukovenko, Anna A.
    Fakhretdinova, Liliya N.
    Safi, Ariana S.
    Zhirenkina, Ekaterina N.
    Polyakova, Irina N.
    Belozerova, Natalia S.
    V. Klykov, Vladislav
    Savelieva, Arina P.
    Ekimov, Aleksey A.
    V. Pokachalov, Konstantin
    Merkulov, Vadim A.
    Yudin, Sergei M.
    Kruchko, Daria S.
    Berzin, Igor A.
    Skvortsova, Veronika I.
    JOURNAL OF INFECTION, 2024, 89 (05)
  • [26] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation
    Cuffari, Carmen
    Spalding, William
    Achenbach, Heinrich
    Thakur, Manoj
    Gabriel, Andre
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
  • [27] Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
    Dixon, Barry
    Smith, Roger J.
    Campbell, Duncan J.
    Moran, John L.
    Doig, Gordon S.
    Rechnitzer, Thomas
    MacIsaac, Christopher M.
    Simpson, Nicholas
    van Haren, Frank M. P.
    Ghosh, Angajendra N.
    Gupta, Sachin
    Broadfield, Emma J. C.
    Crozier, Timothy M. E.
    French, Craig
    Santamaria, John D.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (04) : 360 - 372
  • [28] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Gene Colice
    Janet M. Griffiths
    Gun Almqvist
    Sandhia Ponnarambil
    Primal Kaur
    Gennaro Ruberto
    Karin Bowen
    Åsa Hellqvist
    May Mo
    Esther Garcia Gil
    Respiratory Research, 21
  • [29] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Colice, Gene
    Griffiths, Janet M.
    Almqvist, Gun
    Ponnarambil, Sandhia
    Kaur, Primal
    Ruberto, Gennaro
    Bowen, Karin
    Hellqvist, Asa
    Mo, May
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [30] Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
    Tadao Akizawa
    Manabu Iwasaki
    Tetsuro Otsuka
    Michael Reusch
    Toshihiro Misumi
    Advances in Therapy, 2019, 36 : 1438 - 1454
12345